As we stand on the brink of the personalized medicine era, breakthroughs in areas like genomics are opening up a whole new range of privacy, reliability and security issues. Embedding security and privacy within strategy empowers Life Sciences companies.
Cyber attacks and their consequences have been a reality faced by Swiss businesses for some time now: A survey conducted by KPMG Switzerland shows that nearly half (42%) of the companies that have been the victims of a cyber attack suffered financial losses and dis-ruptions to their business activities as a result.
The EU Network and Information Security (NIS) Directive states that from 9 May 2018 onwards, the national legislations in the various EU member states need to be in place. The overall goal of the NIS Directive is to achieve an high common level of security of networks and information systems within the EU.